Ensysce Biosciences meets investors at Family Office Summit in Dubai
ENSC•Ensysce Biosciences President James Morrison attended the Family Office Summit in Dubai on October 15, 2026, and met with Middle Eastern family offices about investor relationships and potential strategic partnerships. The company submitted a Phase 2a study protocol for CY200, targeting complex regional pain syndrome, to UK regulators in September 2026.
1. Summit meetings
President James Morrison attended the Family Office Summit in Dubai on October 15, 2026. Meetings with Middle Eastern family offices focused on building long-term investor relationships and potential strategic partnerships.
2. CY200 protocol
Ensysce Biosciences submitted a Phase 2a study protocol for CY200, targeting complex regional pain syndrome, to UK regulators in September 2026.
